Better.life

Search Preview

Bayer: Science For A Better Life

www.better.life/

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture.

Most Used Html Elements

  • <a> : 659
  • <li> : 624
  • <ul> : 115
  • <div> : 104
  • <h2> : 21
  • <img> : 17
  • <meta> : 16
  • <span> : 16
  • <source> : 12
  • <p> : 11
  • <script> : 11
  • <h1> : 10
  • <link> : 9
  • <hr> : 8
  • <picture> : 6
  • <h4> : 5
  • <h3> : 5
  • <em> : 3
  • <nav> : 3
  • <style> : 2
  • <input> : 2

Most Used Html Classes

  • "haschild" : 165
  • "" : 30
  • "newsub" : 29
  • "ir" : 15
  • "lnk-w" : 15
  • "lnk" : 10
  • "mlnk" : 10
  • "notmobile" : 9
  • "footer-sitemap__col" : 8
  • "footer-sitemap__head..." : 8
  • "newlevel2" : 7
  • "thdln" : 7
  • "lazy" : 7
  • "megatsrbx" : 7
  • "follow-us__item" : 6
  • "follow-us__link" : 6
  • "mp-item" : 6
  • "mp-teaser" : 6
  • "linkindicator" : 6
  • "nobulls" : 6
  • "media" : 5
  • "whitelabel" : 5
  • "service-footer__col" : 5
  • "selects" : 5
  • "more" : 5
  • "hdln" : 5
  • "unit" : 5
  • "bd" : 5
  • "bll-btn" : 4
  • "colhead" : 4
  • "h5" : 4
  • "margiblock" : 4
  • "width2" : 4
  • "height2" : 4
  • "last" : 3
  • "service-footer__link..." : 3
  • "clearfix" : 3
  • "newsdate" : 3
  • "newsheadline" : 3
  • "newstopline" : 3
  • "n2" : 2
  • "n3" : 2
  • "n4" : 2
  • "width4" : 2
  • "height1" : 2
  • "selected" : 2
  • "plntxt" : 2
  • "n9" : 2
  • "mlang" : 2
  • "n5" : 2
  • "img" : 2
  • "lightgreybg" : 2
  • "cright-item" : 2
  • "extra-nav" : 2
  • "n8" : 2
  • "size-col-a" : 2
  • "protected" : 2
  • "n6" : 2
  • "n7" : 2
  • "clear" : 2

Where is www.better.life hosted?

Country:
United States
City:
Cambridge
Latitude:
42.36
Longitude:
-71.08
IP address:
23.193.34.181
IP Binary address:
10111110000010010001010110101
IP Octal address:
2760221265
IP Hexadecimal address:
17c122b5

Context analysis of better.life

Number of letters on this page:
10 812
Number of words on this page:
2 063
Number of sentences on this page:
28
Average words per sentences on this page:
74
Number of syllables on this page:
3 645

Domain name architecture

Domain name length:
11
Hyphens:
Domain doesn't contain hyphens!
Domain name with Hindi letters:
(b) ए ट ट ए र . ल इ फ़ ए
Domain name with Hebrew letters:
בּ (e) ת ת (e) ר . ל (i) ף (e)
Domain name with Cyrillic letters:
б e т т e р . л и φ e
Domain name with Arabic letters:
ب (e) ت ت (e) ر . ل (i) ف (e)
Domain name with Greek letters:
ε τ τ ε ρ . λ ι φ ε
Domain name with Chinese letters:
比 伊 提 提 伊 艾儿 . 艾勒 艾 艾弗 伊
Domain without Consonants:
bttr.lf
Domain without Vowels:
ee.ie
Alphabet positions:
b2 e5 t20 t20 e5 r18 . l12 i9 f6 e5
Domain name pattern:
V: Vowel, C: Consonant, N: Number
C V C C V C . C V C V

<HEAD> DATA INFORMATION

Encoding:
utf-8
description:
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture.
keywords:
Bayer, Homepage, pharma, Corporate, Dekkers, Board,Management, Supervisory, sites, Publications, Research, Innovations, Products, Social, Sustainability, Responsibility, Sports, donations, events, investor, shareholders, quarterly, reports, annual, press, jobs, locations, career, News, stock, stocks, subgroups, pharmaceutical, health, agriculture, plant, protection
robots:
Index,Follow
copyright:
© Bayer AG, Leverkusen, Germany
author:
Bayer AG
generator:
onpublix 7
publisher:
Bayer AG Communications, Government Relations & Corporate Brand
revisit-after:
14 days
viewport:
width=device-width, initial-scale=1.0, user-scalable=yes
WT.es:
/en/Home/homepage.aspx

External links in better.life

  • http://www.investor.bayer.de/en/overview/
  • http://www.investor.bayer.de/en/bayer-group/ueberblick/key-figures/
  • http://www.investor.bayer.de/en/bayer-group/ueberblick/profile-and-organization/
  • http://www.investor.bayer.de/en/bayer-group/ueberblick/subsidiaries/
  • http://www.investor.bayer.de/en/bayer-group/ueberblick/acquisitions-and-divestitures/
  • http://www.investor.bayer.de/en/bayer-group/ueberblick/our-products/
  • http://www.investor.bayer.de/en/bayer-group/ueberblick/markets-and-economic-outlook/
  • http://www.investor.bayer.de/en/bayer-group/ueberblick/research-development/
  • http://www.investor.bayer.de/en/bayer-group/ueberblick/bayersocial-media/
  • http://www.investor.bayer.de/en/bayer-group/ueberblick/brochure-names-figures-facts/
  • http://www.investor.bayer.de/en/bayer-group/mission-values/
  • http://www.investor.bayer.de/en/bayer-group/strategic-alignment/group-strategy/
  • http://www.investor.bayer.de/en/bayer-group/strategic-alignment/business-strategies/
  • http://www.investor.bayer.de/en/bayer-group/strategic-alignment/value-based-performance/
  • http://www.investor.bayer.de/en/bayer-group/outlook-and-targets/
  • http://www.investor.bayer.de/en/bayer-group/opportunity-and-risk-report/
  • http://www.investor.bayer.de/en/bayer-group/corporate-governance/
  • http://www.investor.bayer.de/en/bayer-group/articles-of-incorporation/
  • http://www.investor.bayer.de/en/bayer-group/board-of-management/
  • http://www.investor.bayer.de/en/bayer-group/supervisory-board/
  • http://www.investor.bayer.de/en/bayer-group/sustainability-and-commitment/
  • http://www.investor.bayer.de/en/stock/investors/key-messages-to-investors/
  • http://www.investor.bayer.de/en/stock/investors/new-investors/
  • http://www.investor.bayer.de/en/stock/investors/institutional-investors/
  • http://www.investor.bayer.de/en/stock/investors/private-investors/
  • http://www.investor.bayer.de/en/bonds/overview/
  • http://www.investor.bayer.de/en/stock/investors/socially-responsible-investing/
  • http://www.investor.bayer.de/en/stock/listing-and-key-figures/basic-data/
  • http://www.investor.bayer.de/en/stock/listing-and-key-figures/key-figures/
  • http://www.investor.bayer.de/en/stock/listing-and-key-figures/share-listings/
  • http://www.investor.bayer.de/en/stock/listing-and-key-figures/equity-indices/
  • http://www.investor.bayer.de/en/stock/listing-and-key-figures/adr-program/
  • http://www.investor.bayer.de/en/stock/share-price/current-share-price/
  • http://www.investor.bayer.de/en/stock/share-price/charts/
  • http://www.investor.bayer.de/en/stock/share-price/closing-prices/
  • http://www.investor.bayer.de/en/stock/dividends/
  • http://www.investor.bayer.de/en/stock/profitability/
  • http://www.investor.bayer.de/en/stock/analysts/analysts-ratings/
  • http://www.investor.bayer.de/en/stock/analysts/consensus/
  • http://www.investor.bayer.de/en/stock/stockholders-portal/
  • http://www.investor.bayer.de/en/stock/ownership-structure/overview/
  • http://www.investor.bayer.de/en/stock/ownership-structure/voting-rights-announcements/
  • http://www.investor.bayer.de/en/stock/ownership-structure/archive-voting-rights-announcements/
  • http://www.investor.bayer.de/en/stock/stock-programs/overview/
  • http://www.investor.bayer.de/en/stock/stock-programs/aspire/
  • http://www.investor.bayer.de/en/stock/stock-programs/participation-program/
  • http://www.investor.bayer.de/en/stock/stock-history/
  • http://www.investor.bayer.de/en/stock/glossary/
  • http://www.investor.bayer.de/en/stock/archive/
  • http://www.investor.bayer.de/en/bonds/financial-strategy/financial-management/
  • http://www.investor.bayer.de/en/bonds/financial-strategy/liability-mix/
  • http://www.investor.bayer.de/en/bonds/financial-strategy/maturity-profile/
  • http://www.investor.bayer.de/en/bonds/financial-strategy/net-financial-debt/
  • http://www.investor.bayer.de/en/bonds/financial-strategy/credit-default-swaps/
  • http://www.investor.bayer.de/en/bonds/funding-instruments/overview/
  • http://www.investor.bayer.de/en/bonds/funding-instruments/debt-issuance-programme/
  • http://www.investor.bayer.de/en/bonds/funding-instruments/commercial-paper-programme/
  • http://www.investor.bayer.de/en/bonds/funding-instruments/syndicated-loan-facility/
  • http://www.investor.bayer.de/en/bonds/bonds-issued/
  • http://www.investor.bayer.de/en/bonds/rating/
  • http://www.investor.bayer.de/en/bonds/bond-news/
  • http://www.investor.bayer.de/en/bonds/credit-analysts/
  • http://www.investor.bayer.de/en/bonds/credit-relations/
  • http://www.investor.bayer.de/en/reports/annual-reports/overview/
  • http://www.investor.bayer.de/en/reports/annual-reports/key-figures-comparison/
  • http://www.investor.bayer.de/en/reports/annual-reports/financial-position/
  • http://www.investor.bayer.de/en/reports/annual-reports/income-statement/
  • http://www.investor.bayer.de/en/reports/annual-reports/cashflow-statement/
  • http://www.investor.bayer.de/en/reports/annual-reports/segment-overview/
  • http://www.investor.bayer.de/en/reports/annual-reports/region-overview/
  • http://www.investor.bayer.de/en/reports/annual-reports/five-year-summary/
  • http://www.investor.bayer.de/en/reports/quarterly-reports/
  • http://www.investor.bayer.de/en/reports/bayer-ag-financial-statements/
  • http://www.investor.bayer.de/en/reports/sustainability-reports/
  • http://www.investor.bayer.de/en/reports/archive/
  • http://www.investor.bayer.de/en/events/calendar/
  • http://www.investor.bayer.de/en/events/live-events/xarelto-compass-data-at-esc-congress-2017/
  • http://www.investor.bayer.de/en/events/live-events/q2-2017-conference-call/
  • http://www.investor.bayer.de/en/events/live-events/q1-2017-conference-call/
  • http://www.investor.bayer.de/en/events/live-events/meet-management-2017-in-london/
  • http://www.investor.bayer.de/en/events/live-events/fyq4-2016-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2016/bayer-to-acquire-monsanto/
  • http://www.investor.bayer.de/en/events/investor-conferences/
  • http://www.investor.bayer.de/en/events/stockholders-meeting/overview/
  • http://www.investor.bayer.de/en/nc/events/stockholders-meeting/overview/
  • http://www.investor.bayer.de/en/events/stockholders-meeting/asm-2016/
  • http://www.investor.bayer.de/en/events/stockholders-meeting/asm-2015/
  • http://www.investor.bayer.de/en/events/stockholders-meeting/asm-2014/
  • http://www.investor.bayer.de/en/events/stockholders-meeting/asm-2013/
  • http://www.investor.bayer.de/en/events/stockholders-meeting/asm-2012/
  • http://www.investor.bayer.de/en/events/stockholders-meeting/asm-2011/
  • http://www.investor.bayer.de/en/events/stockholders-meeting/asm-2010/
  • http://www.investor.bayer.de/en/events/stockholders-meeting/asm-2009/
  • http://www.investor.bayer.de/en/events/stockholders-meeting/asm-2008/
  • http://www.investor.bayer.de/en/events/stockholders-meeting/asm-2007/
  • http://www.investor.bayer.de/en/events/stockholders-meeting/asm-2006/
  • http://www.investor.bayer.de/en/events/stockholders-meeting/asm-2005/
  • http://www.investor.bayer.de/en/events/stockholders-meeting/extraordinary-asm-2004/
  • http://www.investor.bayer.de/en/events/stockholders-meeting/asm-2004/
  • http://www.investor.bayer.de/en/events/stockholders-meeting/asm-2003/
  • http://www.investor.bayer.de/en/events/stockholders-meeting/asm-2002/
  • http://www.investor.bayer.de/en/events/press-conferences/
  • http://www.investor.bayer.de/en/events/roadshows/
  • http://www.investor.bayer.de/en/events/other-presentations/
  • http://www.investor.bayer.de/en/events/archive/
  • http://www.investor.bayer.de/en/events/archive/2016/
  • http://www.investor.bayer.de/en/events/archive/2016/overview/
  • http://www.investor.bayer.de/en/events/archive/2016/q3-2016-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2016/meet-management-2016/
  • http://www.investor.bayer.de/en/events/archive/2016/q2-2016-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2016/bayer-offers-to-acquire-monsanto/
  • http://www.investor.bayer.de/en/events/archive/2016/q1-2016-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2016/fyq4-2015-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2015/
  • http://www.investor.bayer.de/en/events/archive/2015/overview/
  • http://www.investor.bayer.de/en/events/archive/2015/q3-2015-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2015/finerenone-data-at-esc-congress-2015/
  • http://www.investor.bayer.de/en/events/archive/2015/q2-2015-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2015/meet-management-2015-ny/
  • http://www.investor.bayer.de/en/events/archive/2015/q1-2015-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2015/meet-management-2015-in-berlin/
  • http://www.investor.bayer.de/en/events/archive/2015/fyq4-2014-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2014/
  • http://www.investor.bayer.de/en/events/archive/2014/overview/
  • http://www.investor.bayer.de/en/events/archive/2014/q3-2014-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2014/meet-management-2014-ldn/
  • http://www.investor.bayer.de/en/events/archive/2014/conference-call-2014-09-18-planned-demerger-materialscience/
  • http://www.investor.bayer.de/en/events/archive/2014/q2-2014-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2014/meet-management-2014-ny/
  • http://www.investor.bayer.de/en/events/archive/2014/conference-call-2014-05-06-acquisition-cc-business-merck/
  • http://www.investor.bayer.de/en/events/archive/2014/q1-2014-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2014/meet-management-2014-lev/
  • http://www.investor.bayer.de/en/events/archive/2014/fyq4-2013-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2013/
  • http://www.investor.bayer.de/en/events/archive/2013/overview/
  • http://www.investor.bayer.de/en/events/archive/2013/q3-2013-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2013/meet-management-2013-ldn/
  • http://www.investor.bayer.de/en/events/archive/2013/q2-2013-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2013/meet-management-2013-ny/
  • http://www.investor.bayer.de/en/events/archive/2013/q1-2013-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2013/meet-management-2013-lev/
  • http://www.investor.bayer.de/en/events/archive/2013/fyq4-2012-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2012/
  • http://www.investor.bayer.de/en/events/archive/2012/overview/
  • http://www.investor.bayer.de/en/events/archive/2012/meet-management-in-tokyo/
  • http://www.investor.bayer.de/en/events/archive/2012/q3-2012-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2012/riociguat-data-at-chest-2012/
  • http://www.investor.bayer.de/en/events/archive/2012/q2-2012-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2012/meet-management-2012-ny/
  • http://www.investor.bayer.de/en/events/archive/2012/q1-2012-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2012/conference-call-acc-2012/
  • http://www.investor.bayer.de/en/events/archive/2012/meet-management-2012-lev/
  • http://www.investor.bayer.de/en/events/archive/2012/fyq4-2011-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2012/regorafenib-data-at-asco-gi/
  • http://www.investor.bayer.de/en/events/archive/2011/
  • http://www.investor.bayer.de/en/events/archive/2011/overview/
  • http://www.investor.bayer.de/en/events/archive/2011/china-investor-conference/
  • http://www.investor.bayer.de/en/events/archive/2011/rivaroxaban-data-at-aha-2011/
  • http://www.investor.bayer.de/en/events/archive/2011/q3-2011-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2011/q2-2011-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2011/q1-2011-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2011/rivaroxaban-data-at-acc-2011/
  • http://www.investor.bayer.de/en/events/archive/2011/fyq4-2010-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2010/
  • http://www.investor.bayer.de/en/events/archive/2010/overview/
  • http://www.investor.bayer.de/en/events/archive/2010/q3-2010-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2010/rivaroxaban-data-at-esc-2010/
  • http://www.investor.bayer.de/en/events/archive/2010/q2-2010-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2010/q1-2010-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2010/fyq4-2009-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2009/
  • http://www.investor.bayer.de/en/events/archive/2009/overview/
  • http://www.investor.bayer.de/en/events/archive/2009/rivaroxaban-data-at-ash-2009/
  • http://www.investor.bayer.de/en/events/archive/2009/q3-2009-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2009/q2-2009-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2009/ats20090/
  • http://www.investor.bayer.de/en/events/archive/2009/q1-2009-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2009/fyq4-2008-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2008/
  • http://www.investor.bayer.de/en/events/archive/2008/overview/
  • http://www.investor.bayer.de/en/events/archive/2008/rivaroxaban-data-at-aha-2008/
  • http://www.investor.bayer.de/en/events/archive/2008/q3-2008-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2008/q2-2008-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2008/rivaroxaban-data-at-efort-2008/
  • http://www.investor.bayer.de/en/events/archive/2008/q1-2008-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2008/fyq4-2007-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2007/
  • http://www.investor.bayer.de/en/events/archive/2007/overview/
  • http://www.investor.bayer.de/en/events/archive/2007/rivaroxaban-data-at-ash-2007/
  • http://www.investor.bayer.de/en/events/archive/2007/q3-2007-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2007/q2-2007-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2007/healthcare-investor-day-2007/
  • http://www.investor.bayer.de/en/events/archive/2007/nexavar-data-at-asco-2007/
  • http://www.investor.bayer.de/en/events/archive/2007/q1-2007-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2007/fyq4-2006-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2006/
  • http://www.investor.bayer.de/en/events/archive/2006/overview/
  • http://www.investor.bayer.de/en/events/archive/2006/nexavar-melanoma-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2006/q3-2006-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2006/rivaroxaban-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2006/q2-2006-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2006/q1-2006-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2006/fyq4-2005-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2005/
  • http://www.investor.bayer.de/en/events/archive/2005/overview/
  • http://www.investor.bayer.de/en/events/archive/2005/bayer-rd-investor-day-2005/
  • http://www.investor.bayer.de/en/events/archive/2005/q3-2005-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2005/csfb-chemical-hybrid-tour-2005/
  • http://www.investor.bayer.de/en/events/archive/2005/cropscience-analyst-investor-days/
  • http://www.investor.bayer.de/en/events/archive/2005/q2-2005-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2005/data-on-bay-59-7939-at-isth-2005/
  • http://www.investor.bayer.de/en/events/archive/2005/sorafenib-data-at-asco-2005/
  • http://www.investor.bayer.de/en/events/archive/2005/q1-2005-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2005/spring-investor-conference-2005/
  • http://www.investor.bayer.de/en/events/archive/2004/
  • http://www.investor.bayer.de/en/events/archive/2004/overview/
  • http://www.investor.bayer.de/en/events/archive/2004/fall-investor-conference-2004/
  • http://www.investor.bayer.de/en/events/archive/2004/bay-43-9006-data-at-eortc-symposium/
  • http://www.investor.bayer.de/en/events/archive/2004/csfb-field-trip-on-september-22-2004/
  • http://www.investor.bayer.de/en/events/archive/2004/1h-2004-investor-conference/
  • http://www.investor.bayer.de/en/events/archive/2004/bay-43-9006-data-at-asco-2004/
  • http://www.investor.bayer.de/en/events/archive/2004/q1-2004-conference-call/
  • http://www.investor.bayer.de/en/events/archive/2004/spring-investor-conference-2004/
  • http://www.investor.bayer.de/en/events/archive/2003/
  • http://www.investor.bayer.de/en/events/archive/2003/overview/
  • http://www.investor.bayer.de/en/events/archive/2003/csfb-031121/
  • http://www.investor.bayer.de/en/events/archive/2003/ik-031111/
  • http://www.investor.bayer.de/en/events/archive/2003/tk-031107/
  • http://www.investor.bayer.de/en/events/archive/2003/tk-03-1q/
  • http://www.investor.bayer.de/en/events/archive/2003/ik-030314/
  • http://www.investor.bayer.de/en/events/archive/2002/
  • http://www.investor.bayer.de/en/events/archive/2002/overview/
  • http://www.investor.bayer.de/en/events/archive/2002/ik-0211130/
  • http://www.investor.bayer.de/en/events/archive/2002/ik-020801/
  • http://www.investor.bayer.de/en/events/archive/2002/ik-020315/
  • http://www.investor.bayer.de/en/events/archive/2002/pk-020313/
  • http://www.investor.bayer.de/en/events/archive/2001/
  • http://www.investor.bayer.de/en/events/archive/2001/overview/
  • http://www.investor.bayer.de/en/events/archive/2001/ik-011115/
  • http://www.investor.bayer.de/en/events/archive/2001/investor-conference-call-on-the-acquisition-of-aventis-cropscience/
  • http://www.investor.bayer.de/en/events/archive/2001/tk-aventis-011002/
  • http://www.investor.bayer.de/en/events/archive/2001/ik-010809/
  • http://www.investor.bayer.de/en/events/archive/2001/ik-010316/
  • http://www.investor.bayer.de/en/events/archive/2001/pk-010315/
  • http://www.investor.bayer.de/en/events/archive/2000/
  • http://www.investor.bayer.de/en/events/archive/2000/overview/
  • http://www.investor.bayer.de/en/events/archive/2000/ik-001117/
  • http://www.investor.bayer.de/en/events/archive/2000/ir-conf-000512/
  • http://www.investor.bayer.de/en/events/archive/2000/ik-000317/
  • http://www.investor.bayer.de/en/events/archive/2000/pk-000316/
  • http://www.investor.bayer.de/en/events/archive/1999/
  • http://www.investor.bayer.de/en/inside-information/latest-inside-information/
  • http://www.investor.bayer.de/en/inside-information/archive-overview/
  • http://www.investor.bayer.de/en/inside-information/ad-hoc-2016/
  • http://www.investor.bayer.de/en/inside-information/ad-hoc-2015/
  • http://www.investor.bayer.de/en/inside-information/ad-hoc-2014/
  • http://www.investor.bayer.de/en/inside-information/ad-hoc-2013/
  • http://www.investor.bayer.de/en/inside-information/ad-hoc-2012/
  • http://www.investor.bayer.de/en/inside-information/ad-hoc-2011/
  • http://www.investor.bayer.de/en/inside-information/ad-hoc-2010/
  • http://www.investor.bayer.de/en/inside-information/ad-hoc-2009/
  • http://www.investor.bayer.de/en/inside-information/ad-hoc-2008/
  • http://www.investor.bayer.de/en/inside-information/ad-hoc-2007/
  • http://www.investor.bayer.de/en/inside-information/ad-hoc-2006/
  • http://www.investor.bayer.de/en/inside-information/ad-hoc-2005/
  • http://www.investor.bayer.de/en/inside-information/ad-hoc-2004/
  • http://www.investor.bayer.de/en/inside-information/ad-hoc-2003/
  • http://www.investor.bayer.de/en/inside-information/ad-hoc-2002/
  • http://www.investor.bayer.de/en/inside-information/ad-hoc-2001/
  • http://www.investor.bayer.de/en/inside-information/ad-hoc-2000/
  • http://www.investor.bayer.de/en/inside-information/ad-hoc-1999/
  • http://www.investor.bayer.de/en/inside-information/ad-hoc-1998/
  • http://www.investor.bayer.de/en/news/investor-news/
  • http://www.investor.bayer.de/en/news/press/
  • http://www.investor.bayer.de/en/news/archive/overview/
  • http://www.investor.bayer.de/en/nc/news/archive/investor-news-2016/
  • http://www.investor.bayer.de/en/nc/news/archive/investor-news-2015/
  • http://www.investor.bayer.de/en/nc/news/archive/investor-news-2014/
  • http://www.investor.bayer.de/en/nc/news/archive/investor-news-2013/
  • http://www.investor.bayer.de/en/nc/news/archive/investor-news-2012/
  • http://www.investor.bayer.de/en/nc/news/archive/investor-news-2011/
  • http://www.investor.bayer.de/en/nc/news/archive/investor-news-2010/
  • http://www.investor.bayer.de/en/nc/news/archive/investor-news-2009/
  • http://www.investor.bayer.de/en/nc/news/archive/investor-news-2008/
  • http://www.investor.bayer.de/en/nc/news/archive/investor-news-2007/
  • http://www.investor.bayer.de/en/nc/news/archive/investor-news-2006/
  • http://www.investor.bayer.de/en/nc/news/archive/investor-news-2005/
  • http://www.investor.bayer.de/en/nc/news/archive/investor-news-2004/
  • http://www.investor.bayer.de/en/nc/news/archive/investor-news-2003/
  • http://www.investor.bayer.de/en/nc/news/archive/investor-news-2002/
  • http://www.investor.bayer.de/en/nc/news/archive/investor-news-2001/
  • http://www.investor.bayer.de/en/nc/news/archive/investor-news-2000/
  • http://www.investor.bayer.de/en/handouts/investor-handout/
  • http://www.investor.bayer.de/en/handouts/investor-factsheet/
  • http://www.investor.bayer.de/en/handouts/archive-investor-handouts/
  • http://www.investor.bayer.de/en/handouts/archive-presentations/
  • http://www.investor.bayer.de/en/downloads/current-downloads/
  • http://www.investor.bayer.de/en/downloads/2013-2016/2016/
  • http://www.investor.bayer.de/en/downloads/2013-2016/2015/
  • http://www.investor.bayer.de/en/downloads/2013-2016/2014/
  • http://www.investor.bayer.de/en/downloads/2013-2016/2013/
  • http://www.investor.bayer.de/en/downloads/2008-2012/2012/
  • http://www.investor.bayer.de/en/downloads/2008-2012/2011/
  • http://www.investor.bayer.de/en/downloads/2008-2012/2010/
  • http://www.investor.bayer.de/en/downloads/2008-2012/2009/
  • http://www.investor.bayer.de/en/downloads/2008-2012/2008/
  • http://www.investor.bayer.de/en/downloads/2003-2007/2007/
  • http://www.investor.bayer.de/en/downloads/2003-2007/2006/
  • http://www.investor.bayer.de/en/downloads/2003-2007/2005/
  • http://www.investor.bayer.de/en/downloads/2003-2007/2004/
  • http://www.investor.bayer.de/en/downloads/2003-2007/2003/
  • http://www.investor.bayer.de/en/downloads/1998-2002/2002/
  • http://www.investor.bayer.de/en/downloads/1998-2002/2001/
  • http://www.investor.bayer.de/en/downloads/1998-2002/2000/
  • http://www.investor.bayer.de/en/downloads/1998-2002/1999/
  • http://www.investor.bayer.de/en/downloads/1998-2002/1998/
  • http://www.investor.bayer.de/en/contact/ir-team/
  • http://www.investor.bayer.de/en/order-publications/
  • http://www.investor.bayer.de/en/newsletter/
  • http://www.investor.bayer.de/en/rss-newsfeeds/
  • http://www.investor.bayer.de/en/rss-newsfeeds/rss-help-page/
  • http://www.investor.bayer.de/en/podcasts/
  • http://www.investor.bayer.de/en/mobile-services/
  • http://www.investor.bayer.de/en/mobile-services/sms-service/
  • http://www.investor.bayer.de/en/collected-downloads/
  • http://www.investor.bayer.de/en/nc/new-on-this-site/
  • http://www.investor.bayer.de/en/faqs/
  • https://karriereblog.bayer.de/en/my-work-with-the-global-brand-aspirin/
  • https://www.advancingtogether.com/
  • http://www.covestro.com
  • https://www.facebook.com/Bayer
  • https://twitter.com/bayer
  • https://www.youtube.com/user/BayerTVinternational
  • https://www.linkedin.com/company/bayer
  • https://instagram.com/bayerofficial
  • https://www.bayer.de/de/homepage.aspx
  • http://www.facebook.com/Bayer
  • http://twitter.com/bayer
  • http://www.youtube.com/user/BayerTVinternational
  • http://www.linkedin.com/company/bayer
  • http://instagram.com/bayerofficial

Internal links in better.life

  • /en/homepage.aspx
  • #nav
  • https://secure.bayer.com/bayer-group/contact.aspx?lang=en
  • #socialbar
  • #search
  • /de/homepage.aspx
  • /en/Bayer-Group.aspx
  • /en/bayer-group.aspx
  • /en/profile-and-organization.aspx
  • /en/societal-needs-and-our-solutions.aspx
  • /en/bayer-mission-science-for-a-better-life.aspx
  • /en/working-at-bayer.aspx
  • /en/bayer-worldwide.aspx
  • /en/procurement.aspx
  • /en/corporate-compliance-policy.aspx
  • /en/Corporate-Governance.aspx
  • /en/political-involvement.aspx
  • /en/history.aspx
  • /en/Board-of-Management.aspx
  • /en/supervisory-board-of-bayer-ag.aspx
  • /en/calendar.aspx
  • /en/contact.aspx
  • /en/research-and-innovation.aspx
  • /en/exhibition-science-for-a-better-life-tour.aspx
  • /en/Research-at-Bayer.aspx
  • /en/bayer-lifescience-center.aspx
  • /en/bayer-lifescience-ihub.aspx
  • /en/open-innovation.aspx
  • /en/research-the-bayer-scientific-magazine.aspx
  • /en/Inventive-Talent.aspx
  • /en/otto-bayer-medal.aspx
  • /en/products-overview.aspx
  • /en/product-portfolio-of-bayer.aspx
  • /en/currenta.aspx
  • /en/risks-benefits-drugs-patient-information.aspx
  • /en/beware-of-counterfeits.aspx
  • /en/report-an-adverse-side-effect.aspx
  • /en/products-from-a-to-z.aspx
  • /en/sustainability.aspx
  • /en/sustainabilitystrategy.aspx
  • /en/health.aspx
  • /en/sustainability-management.aspx
  • /en/supplier-management.aspx
  • /en/employees.aspx
  • /en/product-stewardship.aspx
  • /en/sustainable-partnerships.aspx
  • /en/safety.aspx
  • /en/environmental-protection.aspx
  • /en/social-responsibility.aspx
  • /en/reporting-principles.aspx
  • /en/awards.aspx
  • /en/straightforward.aspx
  • /en/media.aspx
  • http://press.bayer.com/baynews/baynews.nsf/id/news-overview-category-search-en?opendocument
  • http://press.bayer.com/baynews/baynews.nsf/id/EN_Werner_Baumann?opendocument
  • http://press.bayer.com/baynews/baynews.nsf/id/EN_Johannes_Dietsch?opendocument
  • http://press.bayer.com/baynews/baynews.nsf/id/EN_Hartmut_Klusik?opendocument
  • http://press.bayer.com/baynews/baynews.nsf/id/EN_Kemal_Malik?opendocument
  • http://press.bayer.com/baynews/baynews.nsf/id/EN_Dieter_Weinand?opendocument
  • http://press.bayer.com/baynews/baynews.nsf/id/EN_Erica_Mann?opendocument
  • http://press.bayer.com/baynews/baynews.nsf/id/EN_Liam_Condon?opendocument
  • http://press.bayer.com/baynews/baynews.nsf/id/EN_Werner_Wenning?opendocument
  • http://press.bayer.com/baynews/baynews.nsf/id/EN_Oliver_Zuehlke?opendocument
  • http://press.bayer.com/baynews/baynews.nsf/id/Speeches?opendocument
  • http://press.bayer.com/baynews/baynews.nsf/id/Photos?opendocument
  • http://www.tv-footage.bayer.com
  • /en/Publications.aspx
  • /en/videos.aspx
  • /en/social-media-room.aspx
  • /en/bayer-apps.aspx
  • http://press.bayer.com/baynews/baynews.nsf/id/EN_Events?opendocument
  • /en/aspirin.aspx
  • /en/ecard-overview.aspx
  • http://press.bayer.com/baynews/baynews.nsf/id/Media-Contact?opendocument
  • /en/annual-stockholders-meeting-2017.aspx
  • http://www.career.bayer.com/en/career/
  • http://career.bayer.com/en/career/index.html
  • http://career.bayer.com/en/career/whybayer/
  • http://career.bayer.com/en/career/whybayer/index.html
  • http://career.bayer.com/en/career/whybayer/innovation-solutions/
  • http://career.bayer.com/en/career/whybayer/development-teamwork/
  • http://career.bayer.com/en/career/whybayer/better-life-challenges/
  • http://career.bayer.com/en/career/whybayer/reputation-impact/
  • http://career.bayer.com/en/career/whybayer/benefits-rewards/
  • http://career.bayer.com/en/career/whybayer/values-stories/
  • http://career.bayer.com/en/career/whybayer/values-stories/index.html
  • http://career.bayer.com/en/career/whybayer/values-stories/david-against-goliath/
  • http://career.bayer.com/en/career/whybayer/values-stories/singapores-supertrees/
  • http://career.bayer.com/en/career/whybayer/values-stories/sky-high-vegetables/
  • http://career.bayer.com/en/career/whybayer/values-stories/bringing-light-into-darkness/
  • http://career.bayer.com/en/career/whybayer/values-stories/rice-for-a-hungry-planet/
  • http://career.bayer.com/en/career/whybayer/values-stories/bridging_distances/
  • http://career.bayer.com/en/career/whybayer/values-stories/healthy_for_life/
  • http://career.bayer.com/en/career/whybayer/values-stories/work_and_life_balance/
  • http://career.bayer.com/en/career/whybayer/values-stories/secret_of_the_bridge/
  • http://career.bayer.com/en/career/working-at-bayer/
  • http://career.bayer.com/en/career/working-at-bayer/index.html
  • http://career.bayer.com/en/career/working-at-bayer/students/
  • http://career.bayer.com/en/career/working-at-bayer/graduates/
  • http://career.bayer.com/en/career/working-at-bayer/graduates/index.html
  • http://career.bayer.com/en/career/working-at-bayer/graduates/comput/
  • http://career.bayer.com/en/career/working-at-bayer/graduates/ifm/
  • http://career.bayer.com/en/career/working-at-bayer/graduates/ifm/index.html
  • http://career.bayer.com/en/career/working-at-bayer/graduates/ifm/controlling/
  • http://career.bayer.com/en/career/working-at-bayer/graduates/ifm/accounting/
  • http://career.bayer.com/en/career/working-at-bayer/graduates/ifm/internal-audit/
  • http://career.bayer.com/en/career/working-at-bayer/graduates/ifm/finance/
  • http://career.bayer.com/en/career/working-at-bayer/graduates/international_hr_trainee_program/
  • http://career.bayer.com/en/career/working-at-bayer/graduates/internationales-operations-leader-program/
  • http://career.bayer.com/en/career/working-at-bayer/graduates/global-trainee-program-for-pharmaceutical-production/
  • http://career.bayer.com/en/career/working-at-bayer/graduates/global-trainee-program-for-supply-chain-management/
  • http://career.bayer.com/en/career/working-at-bayer/graduates/procurement-trainee-program/
  • http://career.bayer.com/en/career/working-at-bayer/graduates/international-trainee-program-for-engineers/
  • http://career.bayer.com/en/career/working-at-bayer/professionals/
  • http://career.bayer.com/en/career/working-at-bayer/worldwide/
  • http://career.bayer.com/en/career/how-to-join-us/
  • http://career.bayer.com/en/career/how-to-join-us/index.html
  • http://career.bayer.com/en/career/how-to-join-us/how-to-apply/
  • http://career.bayer.com/en/career/how-to-join-us/the-interview/
  • http://career.bayer.com/en/career/video-center/
  • http://career.bayer.com/en/career/contact-us/
  • https://www.magazine.bayer.com/
  • #
  • #showpanel1
  • #showpanel2
  • #showpanel3
  • #contact
  • #print
  • #share
  • https://www.magazine.bayer.com/en/living-with-cancer.aspx
  • #article10020
  • https://www.cropscience.bayer.com/en/stories/2017/a-champion-of-agriculture-the-canadian-style-of-farming
  • http://pharma.bayer.com/en/innovation-partnering/research-focus/cardiovascular/bayer-at-esc-congress-2017/
  • http://www.news.bayer.com/baynews/baynews.nsf/id/Bayers-Xarelto-significantly-lowered-combined-stroke-cardiovascular-death-heart-attack-patients
  • http://www.news.bayer.com/baynews/baynews.nsf/id/Bayer-will-continue-to-work-constructively-with-the-European-Commission
  • http://www.news.bayer.com/baynews/baynews.nsf/id/Bayer-Receives-EU-Approval-Stivarga-regorafenib-Second-Line-Systemic-Treatment-Liver-Cancer
  • http://www.news.bayer.com/baynews/baynews.nsf/id/news-overview-category-search-en
  • /en/productlinklist/rest/callback_callback.aspx
  • /module/json/LinklistTopics/rest/lang_en/callback_callback.aspx
  • /module/json/LinklistOrganization/rest/lang_en/callback_callback.aspx
  • /module/json/LinklistCountrys/rest/lang_en/callback_callback.aspx
  • /downloads/modern-slavery-act-statement.pdfx?forced=true
  • http://www.bayer.com/en/calendar.aspx
  • http://www.foundations.bayer.com/
  • http://www.sport.bayer.com/
  • /en/publications.aspx
  • http://www.video-center.bayer.com/
  • /en/rss.aspx
  • /en/social-media-channels.aspx
  • /en/sitemap.aspx
  • /en/conditions-of-use.aspx
  • /en/privacy-statement.aspx
  • /en/imprint.aspx
  • /en/technical-details.aspx
  • https://pharma.bayer.com/
  • https://www.bayer.com/en/comsumer-health-division.aspx
  • https://www.cropscience.bayer.com/
  • http://animalhealth.bayer.com/
  • https://www.bayer.com/en/products-from-a-to-z.aspx
  • https://www.bayer.com/en/bayer-worldwide.aspx
  • http://www.research.bayer.com/
  • http://www.annualreport.bayer.com/
  • http://www.quarterly-report.bayer.com/
  • https://www.bayer.com/en/publications.aspx
  • https://www.bayer.com/en/contact.aspx
  • https://www.career.bayer.com/en/career/job-search/index.html
  • http://press.bayer.com/
  • https://www.bayer.com/en/newsletter-overview.aspx
  • http://www.investor.bayer.com/en/stock/share-price/current-share-price/
  • https://www.bayer.com/en/rss.aspx

Possible email addresses for better.life

  • info@better.life
  • email@better.life
  • support@better.life
  • contact@better.life
  • admin@better.life
  • postmaster@better.life
  • hostmaster@better.life
  • domain@better.life
  • abuse@better.life

Possible Domain Typos

www.etter.life, www.bvetter.life, www.vetter.life, www.bfetter.life, www.fetter.life, www.bgetter.life, www.getter.life, www.bhetter.life, www.hetter.life, www.bnetter.life, www.netter.life, www.b etter.life, www. etter.life, www.btter.life, www.bewtter.life, www.bwtter.life, www.bestter.life, www.bstter.life, www.bedtter.life, www.bdtter.life, www.beftter.life, www.bftter.life, www.bertter.life, www.brtter.life, www.be3tter.life, www.b3tter.life, www.be4tter.life, www.b4tter.life, www.beter.life, www.betrter.life, www.berter.life, www.betfter.life, www.befter.life, www.betgter.life, www.begter.life, www.bethter.life, www.behter.life, www.betyter.life, www.beyter.life, www.bet5ter.life, www.be5ter.life, www.bet6ter.life, www.be6ter.life, www.beter.life, www.bettrer.life, www.betrer.life, www.bettfer.life, www.betfer.life, www.bettger.life, www.betger.life, www.betther.life, www.bether.life, www.bettyer.life, www.betyer.life, www.bett5er.life, www.bet5er.life, www.bett6er.life, www.bet6er.life, www.bettr.life, www.bettewr.life, www.bettwr.life, www.bettesr.life, www.bettsr.life, www.bettedr.life, www.bettdr.life, www.bettefr.life, www.bettfr.life, www.betterr.life, www.bettrr.life, www.bette3r.life, www.bett3r.life, www.bette4r.life, www.bett4r.life, www.bette.life, www.bettere.life, www.bettee.life, www.betterd.life, www.betted.life, www.betterf.life, www.bettef.life, www.betterg.life, www.betteg.life, www.better4,.life, www.bette4,.life, www.bettert.life, www.bettet.life, www.better5.life, www.bette5.life,

More Sites

Rechtsanwältin Christina Skjefstad Bremen
Rechtanwältin Christina Skejfstad - Ihre Anwältin in Bremen für Erbrecht, Pferderecht, Mediation, Immobilienrecht,Verkehrsstrafrecht und Versicherungsrecht
Number of used Technologies: 0
Number of used Javascript files: 0
Server Software: Apache/2.2.31 (Unix)
Server Location: Germany / Berlin - 81.169.145.78
List of used Technologies: CSS (Cascading Style Sheets), Html (HyperText Markup Language)
Optometrist in Cypress, TX | Distinct Eye Care
Optometrist in Cypress, TX - Distinct Eye Care is an affordable, skilled Optometrist in Cypress, TX. Accepting new appointments. Call today or request an appointment on our website.
Number of used Technologies: 9
Number of used Javascript files: 9
Server Software: Apache/2.4.27 (cPanel) OpenSSL/1.0.2k mod_bwlimited/1.4
Server Location: United States / Lansing - 67.225.140.109
List of used Technologies: Wordpress CMS, Google Analytics, CSS (Cascading Style Sheets), Flexslider, Google Font API, Html (HyperText Markup Language), Iframe, Javascript, Php (Hypertext Preprocessor), Pingback, SVG (Scalable Vector Graphics), Facebook Box
Timothy Lawrence
Number of used Technologies: 3
Number of used Javascript files: 3
Server Software: cloudflare-nginx
Server Location: United States / San Francisco - 198.41.209.118
List of used Technologies: CSS (Cascading Style Sheets), Google Font API, Html (HyperText Markup Language), SVG (Scalable Vector Graphics)
毎日のくらしをともにしたい、とっておきの器｜マルヒ肥田陶器
陶磁器や美濃焼、ギフトをお探しの方は岐阜県土岐市にあるマルヒ肥田陶器にお任せください。
Number of used Technologies: 6
Number of used Javascript files: 6
Server Software: Apache
Server Location: Japan / - 211.13.196.164
List of used Technologies: Wordpress CMS, CSS (Cascading Style Sheets), Html (HyperText Markup Language), Javascript, jQuery, Php (Hypertext Preprocessor), Pingback
fukuseikai.com
Number of used Technologies: 2
Number of used Javascript files: 2
Server Software: nginx
Server Location: United States / San Antonio - 50.56.81.119
List of used Technologies: Google Analytics, Google Adsense, CSS (Cascading Style Sheets), Html (HyperText Markup Language), Html5, Javascript, Php (Hypertext Preprocessor), CloudFront
:::: SEISA mr La Solución Inteligente ::::
SEISA mr
Number of used Technologies: 0
Number of used Javascript files: 0
Server Software: cloudflare-nginx
Server Location: United States / San Francisco - 104.28.19.57
List of used Technologies: Html (HyperText Markup Language)
Home Accents Plus
Number of used Technologies: 24
Number of used Javascript files: 24
Server Software: Microsoft-IIS/7.5
Server Location: United States / Chicago - 173.236.54.130
List of used Technologies: Wordpress CMS, CSS (Cascading Style Sheets), Font Awesome, Google Font API, Html (HyperText Markup Language), Html5, Iframe, Javascript, jQuery, Php (Hypertext Preprocessor), Pingback, CloudFlare
Shoes, Athletic items in Joe's New Balance Outlet store on forosoftwarez.com!
Shoes, Athletic items in Joe's New Balance Outlet store on forosoftwarez.com!
Number of used Technologies: 8
Number of used Javascript files: 8
Server Software: Apache
Server Location: United States / Los Angeles - 162.222.89.61
List of used Technologies: Carousel, CSS (Cascading Style Sheets), Google Font API, Html (HyperText Markup Language), Html5, Javascript, jQuery Colorbox, jQuery Cookie, jQuery UI
Maklerbüro Kopsch | Ihr Maklerbüro in Leipzig
Unsere Geschäftsfelder liegen in Beratung und Betreuung und der Erarbeitung von Konzepten für private und gewerbliche Kunden.
Number of used Technologies: 0
Number of used Javascript files: 0
Server Software: Apache
Server Location: Germany / - 85.13.153.17
List of used Technologies: CSS (Cascading Style Sheets), Html (HyperText Markup Language), Php (Hypertext Preprocessor)
Farmacêutico Clínico
Serviços de farmacêuticos especializados na área de Farmacologia Clínica e Atenção Farmacêutica.
Number of used Technologies: 2
Number of used Javascript files: 2
Server Software: Pepyaka/1.11.3
Server Location: Ireland / Dublin - 52.31.56.53
List of used Technologies: Wix.com - Free Website Builder, Html (HyperText Markup Language), Html5, Javascript, Php (Hypertext Preprocessor)